{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ASMB/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T17:25:38.540Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":2883,"canonical_name":"ASSEMBLY BIOSCIENCES, INC.","cik":"0001426800","uei":null,"lei":null,"duns":null,"ticker":"ASMB"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":18},"count":18,"timeline":[{"ts":"2026-08-20","kind":"sec.filing","form_type":"S-8","title":"S-8 — ASSEMBLY BIOSCIENCES, INC. — 2026-08-20","url_slug":"/sec/cik-0001426800/s-8/0001193125-26-359252","accession_number":"0001193125-26-359252","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"8-K/A","title":"8-K/A — ASSEMBLY BIOSCIENCES, INC. — 2026-08-14","url_slug":"/sec/cik-0001426800/8-k-a/0001193125-26-352193","accession_number":"0001193125-26-352193","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — ASSEMBLY BIOSCIENCES, INC. — 2026-08-14","url_slug":"/sec/cik-0001426800/schedule-13g-a/0001104659-26-097209","accession_number":"0001104659-26-097209","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ASSEMBLY BIOSCIENCES, INC. — 2026-08-13","url_slug":"/sec/cik-0001426800/10-q/0001193125-26-349236","accession_number":"0001193125-26-349236","importance":45},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — ASSEMBLY BIOSCIENCES, INC. — 2026-08-13","url_slug":"/sec/cik-0001426800/8-k/0001193125-26-349198","accession_number":"0001193125-26-349198","importance":35},{"ts":"2026-08-04","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — ASSEMBLY BIOSCIENCES, INC. — 2026-08-04","url_slug":"/sec/cik-0001426800/schedule-13g-a/0000908834-26-000380","accession_number":"0000908834-26-000380","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — ASSEMBLY BIOSCIENCES, INC. — 2026-06-18","url_slug":"/sec/cik-0001426800/4/0001193125-26-275804","accession_number":"0001193125-26-275804","importance":30},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Bjorkquist Jeanette M","title":"PFO and PAO","shares":29,"price_per_share":23.25,"usd_value":674,"security_title":"Common Stock","importance":35.00067425},{"ts":"2026-06-05","kind":"sec.filing","form_type":"8-K","title":"8-K — ASSEMBLY BIOSCIENCES, INC. — 2026-06-05","url_slug":"/sec/cik-0001426800/8-k/0001193125-26-259481","accession_number":"0001193125-26-259481","importance":35},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — ASSEMBLY BIOSCIENCES, INC. — 2026-06-05","url_slug":"/sec/cik-0001426800/4/0001193125-26-259742","accession_number":"0001193125-26-259742","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — ASSEMBLY BIOSCIENCES, INC. — 2026-06-05","url_slug":"/sec/cik-0001426800/4/0001193125-26-259776","accession_number":"0001193125-26-259776","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — ASSEMBLY BIOSCIENCES, INC. — 2026-06-05","url_slug":"/sec/cik-0001426800/4/0001193125-26-259808","accession_number":"0001193125-26-259808","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — ASSEMBLY BIOSCIENCES, INC. — 2026-06-05","url_slug":"/sec/cik-0001426800/4/0001193125-26-259822","accession_number":"0001193125-26-259822","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — ASSEMBLY BIOSCIENCES, INC. — 2026-06-05","url_slug":"/sec/cik-0001426800/4/0001193125-26-259855","accession_number":"0001193125-26-259855","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — ASSEMBLY BIOSCIENCES, INC. — 2026-06-05","url_slug":"/sec/cik-0001426800/4/0001193125-26-259924","accession_number":"0001193125-26-259924","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — ASSEMBLY BIOSCIENCES, INC. — 2026-06-05","url_slug":"/sec/cik-0001426800/4/0001193125-26-259927","accession_number":"0001193125-26-259927","importance":30},{"ts":"2026-05-11","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — ASSEMBLY BIOSCIENCES, INC. — 2026-05-11","url_slug":"/sec/cik-0001426800/schedule-13g/0001104659-26-058623","accession_number":"0001104659-26-058623","importance":55},{"ts":"2026-05-11","kind":"sec.13dg","reporter":"ASSEMBLY BIOSCIENCES, INC.","shares":865251,"percent_of_class":5.4,"security_title":"SCHEDULE 13G","accession_number":"0001104659-26-058623","excerpt":null,"importance":55}]}